FindTrial
Sign In

Effect of hericium polypeptide powder and hericium mushroom probiotics solid drink on the Helicobacter pylori infection: A randomized, double-blinded, placebo-controlled trial

Effect of hericium on the Helicobacter pylori infection: A randomized, double-blinded, placebo-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027879
Enrollment
Unknown
Registered
2019-12-01
Start date
2020-03-01
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacteria Pylori

Interventions

Intervention group A:hericium polypeptide powder
Intervention group B:hericium mushroom probiotics solid drink
Control group:Placebo

Sponsors

Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Subjects included in this trial should be aged 20-70 years; diagnosed as HP infection positive; BMI ranged from 18 to 30 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactation, be allergy to products; 2. With heart, liver, kidney, blood system disease; 3. Evidence of drug-induced stomach disease; 4. History of stomach surgery or use of drugs known to cause stomach disease or related to HP infection; 5. Mental or physical disability; 6. Use of nutritional supplements in the past 3 months; 7. Informed consent with signature were not obtained.

Design outcomes

Primary

MeasureTime frame
HP infection;—

Secondary

MeasureTime frame
Pepsinogen(PG);inflammation marker;—

Countries

China

Contacts

Public ContactLipeng Jing

Lanzhou University

jinglp103@163.com+86 15293197918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026